SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutic ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a key way to keep patients safe. But the FDA’s system for collecting data and ...

I had $3,000 when the stock market crashed in 2020. I immediately invested that in stocks, letting myself become homeless ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Lily Vittayarukskul secured an internship at NASA by age 16, but her tech career pivoted to healthcare when her aunt — a ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...